Biological assay for activity and molecular mechanism of retinoids in cervical tumor cells

Gynecologic Oncology

Volumn 66, Issue 1, 1997, Pages 114-121

  Benbrook, Doris M ^a   Lu, Shennan ^a   Flanagan, Cole ^a   Shen Gunther, Jane ^a   Angros, Lee H ^b   Lightfoot, Stan A ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b Biopath Laboratories Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; CELL NUCLEUS RECEPTOR; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; RETINOIC ACID RECEPTOR; RETINOID; RETINOL BINDING PROTEIN;

ARTICLE; CANCER CELL CULTURE; CONCENTRATION RESPONSE; DOSE RESPONSE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SOUTHERN BLOTTING; TRANSACTIVATION; UTERINE CERVIX CANCER;

EID: 0031193551     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4736     Document Type: Article

References (59)

1. Lippman S M, Kavanagh J J, Paredes-Espinoza M, Delgadillo-Madrueno F, Paredes-Casillas P, Hong W K, Holdener E, Krakoff I H. 13-cis retinoic acid plus interferon α-2a: Highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst. 84:1992;241-245.
2. Lippman S M, Kavanagh J J, Paredes-Espinosa M, Delgadiool-Madrueno F, Paredes-Casillas P, Hong W K, Massimini G, Holdener E E, Krakoff I H. 13-cis retinoic acid plus interferon-α-2a in locally advanced squamous cell carcinoma of the cervix. J Natl Cancer Inst. 85:1993;499-500.
3. Romney S L, Palan P R, Duttagupta C, Wassertheil-Smoller S, Lucido D. Retinoids and the prevention of cervical dysplasias. Am J Obstet Gynecol. 141:1981;890-894.
4. Meyskins F L, Graham V, Chvapil M, Dorr R T, Alberts D S, Surwit E A. A phase I trial of β-all-trans-retinoic acid delivered via collagen sponge and cervical cap for mild or moderate intraepithelial cervical neoplasia. J Natl Cancer Inst. 71:1983;921-925.
5. Graham V, Surwit E S, Weiner S, Meyskens F L. Phase II trial of β-all-trans-retinoic acid for cervical intraepithelial neoplasia delivered via collagen sponge and cervical cap. West J Med. 145:1986;192-195.
6. Meyskens F L, Surwit E S. Clinical experience with topical tretinoin in the treatment of cervical dysplasia. J Am Acad Dermatol. 15:1986;826-829.
7. Weiner S A, Surwit E A, Graham V E, Meyskens F L. A phase I trial of topically appliedtrans-retinoic acid in cervical dysplasia - Clinical efficacy. Invest New Drugs. 4:1986;241-244.
8. Beral V, Hermon C, Munoz N, Devesa S S. Cervical cancer. Cancer Surveys. 19-20:1994;265-285.
9. zur Hausen H. Papillomaviruses in human cancers. Mol Carcin. 1:1988;147-150.
10. Pirisi L, Yasumoto S, Feller M, Doninger J K, di Paolo J A. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J Virol. 61:1987;1061-1066.
11. Dürst M, Dzarlieva-Petrusevska R T, Boukamp P, Fusenig N, Gissmann L. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene. 1:1988;251-256.
12. Kaur P, McDougall J K. Characterization of primary human keratinocytes transformed by human papillomavirus type 18. J Virol. 62:1988;1917-1924.
13. Chapman W B, Lorincz A T, Willett G D, Wright V C, Kurman R J. Epidermal growth factor receptor expression and the presence of human papillomavirus in cervical squamous intraepithelial lesions. Int J Gynecol Pathol. 11:1992;221-226.
14. Berchuck A, Rodriguez G, Kamel A, Soper J T, Clarke-Pearson D L, Bast R C. Expression of epidermal growth factor receptor and HER-2/Neu in normal and neoplastic cervix, vulva, and vagina. Obstet Gynecol. 76:1990;381-387.
15. Pfeiffer D, Stellwag B, Pfeiffer A, Borlinghaus P, Meier W, Scheidel P. Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 33:1989;146-150.
16. Hale R J, Buckley C H, Gullick W J, Fox H, Williams J, Wilcox F L. Prognostic value of epidermal growth factor receptor expression in cervical carcinoma. J Clin Pathol. 46:1993;149-153.
17. Tervahauta A, Syrjanen S, Syrjanen K. Epidermal growth factor receptor expression in human papillomavirus lesions of the uterine cervix. Int J Gynecol Pathol. 13:1994;234-240.
18. Hayashi Y, Hachisuga T, Iwasaka T, Fukuda K, Okuma Y, Yokoyama M, Sugimori H. Expression of ras oncogene product and EGF receptor in cervical squamous cell carcinomas and its relationship to lymph node involvement. Gynecol Oncol. 40:1991;147-151.
19. Roberts A B, Anzano M A, Lamb L C, Smith J M, Sporn M B. Antagonistic actions of retinoic acid and dexamethasone on anchorage independent growth and epidermal growth factor binding of normal rat kidney cells. Cancer Res. 44:1984;1635-1641.
20. Chen J K, Li L, Mioh H. Differential responsiveness of normal and simian virus 40-transformed BALB/c 3T3 cell to retinoic acid: Rapid enhancement of epidermal growth factor receptor binding in a simian virus 40-3T3 variant. Cancer Res. 47:1987;4995-4999.
21. Zheng Z S, Goldsmith L A. Modulation of epidermal growth factor receptors by retinoic acid in ME180 cells. Cancer Res. 50:1990;1201-1205.
22. Piazza G A, Ritter J L. Involvement of transforming growth factor-alpha and its receptor in the growth response of cultured human epidermal cells to retinoic acid. Epithel Cell Biol. 2:1993;170-175.
23. Grandis J R, Zeng A, Tweardy D J. Retinoic acid normalizes the increased gene transcription rate of TGF-alpha and EGFR in head and neck cancer cell lines. Nature Med. 2:1995;237-240.
24. Sizemore N, Rorke E A. Human papillomavirus 16 immortalization of normal human ectocervical epithelial cells alters retinoic acid regulation of cell growth and epidermal growth factor receptor expression. Cancer Res. 53:1993;4511-4517.
25. Agarwal C, Rorke E A, Irwin J C, Eckert R L. Immortalization by human papillomavirus type 16 alters retinoid regulation of human ectocervical epithelial cell differentiation. Cancer Res. 51:1991;3982-3989.
26. Pirisi L, Batova A, Jenkins G R, Hodam J R, Creek K E. Increased sensitivity of human keratinocytes immortalized by human papillomavirus type 16 DNA to growth control by retinoids. Cancer Res. 52:1992;187-193.
27. Agarwal C, Hembree J R, Rorke E A, Eckert R L. Interferon and retinoic acid suppress the growth of human papillomavirus type 16 immortalized cervical epithelial cells, but only interferon suppresses the level of the human papillomavirus transforming oncogenes. Cancer Res. 54:1994;2108-2112.
28. Tallman M S, Wiernik P H. Retinoids in cancer treatment. J Clin Pharmacol. 32:1992;868-888.
29. Giguère V. Retinoic acid receptors and cellular retinoid binding proteins: Complex interplay in retinoid signaling. Endocrin Rev. 15:1994;61-79.
30. Petkovich M. Regulation of gene expression by vitamin A: The role of nuclear retinoic acid receptors. Annu Rev Nutr. 12:1992;443-471.
31. Heyman R, Mangelsdorf P, Dyck J, Stien R, Eichele G, Evans R, Thaller C. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell. 68:1992;397-406.
32. Levin A, Sturzenbecker L, Kazmer, Bosakowski T, Huselton C, Allenby G, Speck J, Kratzeisen C, Rosenberger M, Lovey A, Grippo J. 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR α Nature. 355:1992;359-361.
33. Zhang X-k, Lehmann J, Hoffman B, Dawson M I, Cameron J, Graupner G, Hermann T, Tran P, Pfahl M. Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid. Nature. 358:1992;587-591.
34. Palmer C M, Hsu M H, Muerhoff A S, Griffin K J, Johnson E F. Interaction of the peroxisome proliferator-activated receptor alpha with the retinoid X receptor alpha unmasks a cryptic peroxisome proliferator response element that overlaps an ARP-1 binding site in the CYP4A6 promoter. J Biol Chem. 269:1994;18083-18089.
35. Apfel R, Benbrook D, Lernhardt E, Ortiz M A, Salbert G, Pfahl M. A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. Mol Cell Endocrin. 14:1994;7025-7035.
36. Kliewer S A, Umesono K, Heyman R, Mangelsdorf D J, Dyck J A, Evans R M. Retinoid X receptor-Coup-TF interactions modulate retinoic acid signaling. Proc Natl Acad Sci USA. 89:1992;1448-1452.
37. Gianni M, Zanotta S, Terao M, Garattini S, Garattini E. Effects of synthetic retinoids and retinoic acid isomers on the expression of alkaline phosphatase in F9 teratocarcinoma cells. Biochem Biophys Res Commun. 196:1993;252-259.
38. Boylan J F, Lohnes D, Taneja R, Chambon P, Gudas L J. Loss of retinoic acid receptor γ function in F9 cells by gene disruption results in aberrant Hoxa-1 expression and differentiation upon retinoic acid treatment. Proc Natl Acad Sci USA. 90:1993;9601-9605.
39. de The H, Vivanco-Ruiz M, Tiollais P, Stunnenberg H, Dejean A. Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature. 343:1990;177-180.
40. Benbrook D M, Rogers R S, Medlin M A, Dunn S T. Immunohistochemical analysis of proliferation and differentiation in organotypic cultures of cervical tumor cell lines. Tissue Cell. 27:1995;269-274.
41. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
42. Kindmark A, Törmä H, Johansson A G, Sverker L, Melhus H. Cellular retinoic acid-binding protein type II is expressed in adult human osteoblasts and in adult liver. Biochem Biophys Res Commun. 189:1992;1397-1403.
43. Sleigh M J. A nonchromatographic assay for expression of the chloramphenicol acetyltransferase gene in eukaryotic cells. Anal Biochem. 156:1986;251-256.
44. Taylor S R, Titus-Ernstoff L, Stitely S. Central values and variation of measured nuclear DNA content in imprints of normal tissues determined by image analysis. Cytometry. 10:1989;382-387.
45. Loyter A, Scangos G A, Ruddle F H. Mechanisms of DNA uptake by mammalian cells: Fate of exogenously added DNA monitored by the use of fluorescent dyes. Proc Natl Acad Sci USA. 79:1982;422-426.
46. D, M, Benbrook, M, M, Madler, L, W, Spruce, P, Birckbichler, E, C, Nelson, S, Subramanian, G, M, Weerasekare, J, B, Gale, M, K, Patterson, Jr, B, Wang, W, Wang, S, Lu, T, C, Rowland, P, DiSilvestro, K, D, Berlin, C, Lindamood, D, L, Hill, Biologically active heteroarotinoids exhibit anticancer activity and decreased toxicity.
47. Hillemanns P, Tannous-Khuri L, Koulos J P, Talmage D, Wright T C. Localization of cellular retinoid-binding proteins in human cervical intraepithelial neoplasia and invasive carcinoma. Am J Pathol. 141:1992;973-980.
48. Tannous-Khuri L, Hillemans P, Rajan N, Wright T C, Talmage D A. Expression of cellular retinol- and cellular retinoic acid-binding proteins in the rat cervical epithelium is regulated by endocrine stimuli during normal squamous metaplasia. Am J Pathol. 144:1994;148-159.
49. Sanquer S, Eller M S, Gilchrest B A. Retinoids and state of differentiation modulate CRABPII gene expression in a skin equivalent. J Invest Dermatol. 100:1993;148-153.
50. Hu L, Crowe D L, Rheinwald J G, Chambon P, Gudas L J. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res. 51:1991;3972-3981.
51. Gebert J F, Moghal N, Frangioni J V, Sugarbaker D J, Neel B G. High frequency of retinoic acid receptor β abnormalities in human lung cancer. Oncogene. 6:1991;1859-1868.
52. Swisshelm K, Ryan K, Lee X, Tsou H C, Peacocke M, Sager R. Down-regulation of retinoic acid receptor beta in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth Diff. 5:1994;33-141.
53. Zhang X-k, Liu Y, Mi-Ock L, Pfahl M. A specific defect in the retinoic acid response associated with human lung cancer cell lines. Cancer Res. 54:1994;5663-5669.
54. Darwiche N, Celli G, De Luca L M. Specificity of retinoid receptor gene expression in mouse cervical epithelia. Endocrinology. 134:1994;2018-2025.
55. Fong C J, Sutkowski D M, Braun E J, Bauer K D, Sherwood E R, Lee C, Kozlowski J M. Effect of retinoic acid on the proliferation and secretory activity of androgen-responsive prostatic carcinoma cells. J Urol. 149:1993;1190-1194.
56. Pfahl M. Nuclear recptor/AP-1 interaction. Endocrine Rev. 14:1993;651-658.
57. Chen J-Y, Penco S, Ostrowski J, Balaguer P, Pons M, Starrett J E, Reczek P, Chambon P, Gronemeyer H. RAR-specific agonists/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation. EMBO J. 14:1995;1187-1197.
58. von Knebel Doeberitz M, Gissman L, zur Hausen H. Growth-regulating functions of human papillomavirus early gene products in cervical cancer cells acting dominant over enhanced epidermal growth factor receptor expression. Cancer Res. 50:1990;3730-3736.
59. Watanabe S, Kanda T, Yoshiike K. Growth dependence of human papillomavirus 16 DNA-positive cervical cancer cell lines and human papillomavirus 16-transformed human and rat cells on the viral oncoproteins. Jpn J Cancer Res. 84:1993;1043-1049.